

Author: Deeks Emma D. Scott Lesley J.
Publisher: Adis International
ISSN: 1172-7047
Source: CNS Drugs, Vol.20, Iss.9, 2006-01, pp. : 751-760
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content


Reduced seizures a reality with rufinamide
Inpharma, Vol. 1, Iss. 1536, 2006-01 ,pp. :


Rufinamide: A Viewpoint by Gregory Krauss
CNS Drugs, Vol. 20, Iss. 9, 2006-01 ,pp. :


Drugs & Therapy Perspectives, Vol. 23, Iss. 1, 2007-01 ,pp. :


Rufinamide another option in LGS
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 567, 2008-01 ,pp. :


Rufinamide for the treatment of Lennox––Gastaut syndrome
Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 5, 2011-04 ,pp. :